{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:56:30Z","timestamp":1791597390617,"version":"4.3.4"},"reference-count":24,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Herpes simplex virus type 2 (HSV-2) is a common human pathogen that can cause a variety of clinical manifestations in humans. In order to provide near-patient results to allow for faster counseling and treatment, a rapid point-of-care test that is accurate and simple to use is desirable. Here, we describe the development and evaluation of an HSV-2 immunoglobulin G (IgG)-specific antibody lateral-flow immunochromatographic assay (LFIA) based on colloidal gold nanoparticles. A total of 359 serum samples and 100 whole-blood samples were tested in the newly developed HSV-2 LFIA. Serum results were compared to those from the HerpeSelect HSV-2 enzyme-linked immunosorbent assay (ELISA), and whole-blood sample results were compared to those of both ELISA and HerpeSelect HSV-1 and -2 immunoblotting (IB). The sensitivity of the HSV-2 LFIA compared to that of the HerpeSelect ELISA was 100% (89\/89), and the specificity was 97.3% (257\/264). Cross-reactivity with HSV-1 IgG-positive serum samples was observed in 2.6% (5\/196) of samples, 2.9% (1\/34) for rubella virus, and 6.2% (1\/16) for Epstein-Barr virus. No cross-reactivity in varicella-zoster virus or cytomegalovirus IgG-positive serum samples was observed. No interference was observed from bilirubin-, triglyceride-, albumin-, or hemoglobin-spiked samples. The concordance of the LFIA results between capillary whole blood, EDTA-treated venous whole blood, heparin-treated venous whole blood, and serum was 99% (99\/100). In conclusion, the LFIA for HSV-2 IgG-specific antibodies demonstrated excellent sensitivity, specificity, and concordance for both serum and whole-blood samples compared to the sensitivity, specificity, and concordance of both HSV-2 ELISA and IB.<\/jats:p>","DOI":"10.1128\/cvi.00218-07","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T02:04:56Z","timestamp":1195092296000},"page":"159-163","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":97,"title":["Rapid, Sensitive, and Specific Lateral-Flow Immunochromatographic Point-of-Care Device for Detection of Herpes Simplex Virus Type 2-Specific Immunoglobulin G Antibodies in Serum and Whole Blood"],"prefix":"10.1128","volume":"15","author":[{"given":"Elisabeth I.","family":"Laderman","sequence":"first","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Whitworth","sequence":"additional","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erickson","family":"Dumaual","sequence":"additional","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jones","sequence":"additional","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hudak","sequence":"additional","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hogrefe","sequence":"additional","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Carney","sequence":"additional","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Groen","sequence":"additional","affiliation":[{"name":"Research and Development Department, Focus Diagnostics, Inc., Cypress, California"},{"name":"Research and Development Department, BBInternational, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"876","year":"1995","unstructured":"Arvin, A., and C. Prober. 1995. Herpes simplex viruses, p. 876-883. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, DC.","journal-title":"Manual of clinical microbiology"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/sti.77.4.232","volume":"77","year":"2001","unstructured":"Ashley, R. L. 2001. Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect.77:232-237.","journal-title":"Sex. Transm. Infect."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.5.1632-1633.1999"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.1"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00007435-200005000-00005","volume":"27","year":"2000","unstructured":"Ashley, R. L., A. Wald, and M. Eagleton. 2000. Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2. Sex. Transm. Dis.27:266-269.","journal-title":"Sex. Transm. Dis."},{"key":"e_1_3_2_7_2","first-page":"473","year":"1992","unstructured":"Aurelian, L. 1992. Herpes simplex viruses, p. 473-497. In S. Specter and G. Lancz (ed.), Clinical virology manual, 2nd ed. Elsevier, New York, NY.","journal-title":"Clinical virology manual"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-4-10","volume":"4","year":"2004","unstructured":"B\u00fcnzli, D., V. Wietlisbach, F. Barazzoni, R. Sahli, and P. R. Meylan. 2004. Seroepidemiology of herpes simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study. BMC Infect. Dis.4:10.","journal-title":"BMC Infect. Dis."},{"key":"e_1_3_2_9_2","first-page":"1","volume":"51","year":"2002","unstructured":"Centers for Disease Control and Prevention. 2002. Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly. Rep.51:1-80.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_10_2","first-page":"866","volume":"52","year":"2003","unstructured":"Cohen, M. H., Y. Olszewski, M. Robey, and F. Love. 2003. Rapid point-of-care testing for HIV-1 during labor and delivery. Morb. Mortal. Wkly. Rep.52:866-868.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.OLQ.0000092387.58746.C7","volume":"30","year":"2003","unstructured":"Craig, R. M., J. R. Pfister, and S. J. Spear. 2003. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex. Transm. Dis.30:797-800.","journal-title":"Sex. Transm. Dis."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00007435-200302000-00015","volume":"30","year":"2003","unstructured":"Engelberg, R., D. Carrell, E. Krantz, L. Corey, and A. Wald. 2003. Natural history of genital herpes simplex virus type 1 infection. Sex. Transm. Dis.30:174-177.","journal-title":"Sex. Transm. Dis."},{"key":"e_1_3_2_13_2","first-page":"44","volume":"111","year":"1996","unstructured":"Farnham, P. G., R. D. Gorsky, D. R. Holtgrave, W. K. Jones, and M. E. Guinan. 1996. Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Rep.111:44-53.","journal-title":"Public Health Rep."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/sti.2005.018176","volume":"82","year":"2006","unstructured":"Haddow, L. J., B. Dave, A. Mindel, K. A. McPhie, C. Chung, C. Marks, and D. E. Dwyer. 2006. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex. Transm. Infect.82:255-259.","journal-title":"Sex. Transm. Infect."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.10.3635-3640.2002"},{"key":"e_1_3_2_16_2","first-page":"2A","volume":"11","year":"2004","unstructured":"Malkin, J. E. 2004. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes11(Suppl. 1):2A.","journal-title":"Herpes"},{"key":"e_1_3_2_17_2","first-page":"646","volume":"17","year":"2002","unstructured":"McGee, S. 2002. Simplifying likelihood ratios. J. Gen. Int. Med.17:646-649.","journal-title":"J. Gen. Int. Med."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1309\/AKWHF62YYJ054HA6","volume":"120","year":"2003","unstructured":"Morrow, R. A., and D. Friedrich. 2003. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2. Am. J. Clin. Pathol.120:839-844.","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1098-2825(2000)14:1<13::AID-JCLA3>3.0.CO;2-C","volume":"14","year":"2000","unstructured":"Prince, H. E., C. E. Ernst, and W. R. Hogrefe. 2000. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J. Clin. Lab. Anal.14:13-16.","journal-title":"J. Clin. Lab. Anal."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1086\/345771","volume":"186","year":"2002","unstructured":"Schacker, T., J. Zeh, H. Hu, M. Shaughnessy, and L. Corey. 2002. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J. Infect. Dis.186:1718-1725.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_21_2","first-page":"R41-R45","volume":"6","year":"1996","unstructured":"Slomka, M. J. 1996. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Commun. Dis. Rep. CDR Rev.6:R41-R45.","journal-title":"Commun. Dis. Rep. CDR Rev."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03256439","volume":"10","year":"2006","unstructured":"Strick, L. B., and A. Wald. 2006. Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol. Diagn. Ther.10:17-28.","journal-title":"Mol. Diagn. Ther."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/sti.2004.009753","volume":"80","year":"2004","unstructured":"Tran, T., J. D. Druce, M. C. Catton, H. Kelly, and C. J. Birch. 2004. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex. Transm. Infect.80:277-279.","journal-title":"Sex. Transm. Infect."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1086\/342104","volume":"35","year":"2002","unstructured":"Wald, A., and R. Ashley-Morrow. 2002. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin. Infect. Dis.35(Suppl. 2):S173.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1086\/342969","volume":"186","year":"2002","unstructured":"Wald, A., J. Zeh, S. Selke, T. Warren, R. Ashley, and L. Corey. 2002. Genital shedding of herpes simplex virus among men. J. Infect. Dis.186(Suppl. 1):S34.","journal-title":"J. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00218-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00218-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T15:54:29Z","timestamp":1627574069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00218-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1128\/CVI.00218-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00218-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"2007-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-11-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}